denaturation(1) drug(1) COVID‐19(1) secondary structure(1) severe respiratory disease(1) mammalian cell(1) ACE2(1) expressed(1) HEK293 cell(1) spike(1) viral entry(1) RBD(1) host cell(1) receptor‐binding domain(1) lack(1) purified(1) Neutralizing antibodies(1) rational design(1) virus(1) SARS‐CoV‐2(1) Escherichia coli(1) low expression(1) Host(1) pandemic(1) the vaccine(1) characterization(1) SARS‐CoV‐2(1) Spike protein(1) binding(1) E. coli(1)